This inventor holds 2 USPTO granted patents. Top assignee: Tufts University. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2007
Title: George R Flentke: Innovator in Dipeptidyl-Aminopeptidase Inhibitors
Introduction
George R Flentke is a notable inventor based in Boston, MA (US), recognized for his contributions to the field of biochemistry. With a total of 2 patents, Flentke has made significant strides in the development of peptide inhibitors that target dipeptidyl-aminopeptidase type IV (DP-IV).
Latest Patents
Flentke's latest patents focus on inhibitors of dipeptidyl-aminopeptidase type IV. These peptide inhibitors exhibit an isomeric purity of about 96–99 percent. The innovative compounds include one or more amino acids that are covalently coupled to a boroproline moiety. These compounds are valuable as DP-IV inhibitors, both in vivo and in vitro.
Career Highlights
Flentke is affiliated with Tufts University, where he has been able to leverage his expertise in biochemistry to advance research in this critical area. His work has implications for various therapeutic applications, particularly in the management of metabolic disorders.
Collaborations
Flentke has collaborated with esteemed colleagues such as William W Bachovchin and Andrew G Plaut, contributing to a rich environment of innovation and research.
Conclusion
George R Flentke's work in developing peptide inhibitors for dipeptidyl-aminopeptidase type IV showcases his commitment to advancing scientific knowledge and therapeutic options. His contributions continue to impact the field of biochemistry significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile